Picard Medical, Inc. (PMI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Picard Medical, Inc. on February 26, 2026. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Tucson, Arizona. The report discloses a corporate event under Item 7.01 (Regulation FD Disclosure).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a scheduled participation in an industry conference.
Outlook, Commentary, and Risks
Management Commentary and Events: On February 26, 2026, the Company announced it will participate in the "Hands-On Training Day" at the Technology and Heart Failure Therapeutics 2026 conference. The event is scheduled for March 1, 2026, in Boston, Massachusetts.
Legal Disclaimer: The information in this report and its exhibits is not deemed "filed" for purposes of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any other filings.
Investor Verification Checklist
- Verify the date and location of the "Hands-On Training Day" at the Technology and Heart Failure Therapeutics 2026 conference (March 1, 2026, Boston, MA).
- Review the full text of the press release furnished as Exhibit 99.1 for specific details on the training content or product demonstrations.
- Confirm the Company's status as an emerging growth company and its listing on The NYSE American, LLC under the symbol PMI.